Provided by Tiger Trade Technology Pte. Ltd.

Nonprofit Pharmaceutical Companies

499.747
-6.328-1.25%
Number of Gainers:7
Number of Losers:24
Number of Flat:2
PE:- -
High:517.538
Open:506.335
Low:496.695
Close:506.075
Volume:58.05M
Turnover:1.69B
Market Cap:318.90B
Float Cap:284.40B

Loading ...

17 Drugmakers Announce Major Executive Reshuffles in Half a Month

Deep News
·
Aug 17

Zai Lab Ltd: Efgartigimod Continues to be Evaluated as a Potential Treatment in Other Autoimmune Rheumatologic Diseases

THOMSON REUTERS
·
Aug 17

Zai Lab - Phase 3 Study Meets Primary Endpoint of Mean Total Improvement Score at Week 52

THOMSON REUTERS
·
Aug 17

Zai Lab and Argenx Announce Positive Topline Results from Phase 3 Alkivia Trial of Efgartigimod in Autoimmune Myositis

THOMSON REUTERS
·
Aug 17

Zai Lab - Efgartigimod Well-Tolerated with Consistent Safety Profile in Alkivia Study

THOMSON REUTERS
·
Aug 17

Zai Lab Ltd: Patient Improvements Observed Early and Sustained Throughout Study; Consistent Treatment Effect Across Imnm and Dm

THOMSON REUTERS
·
Aug 17

BAIYUNSHAN PH Subsidiary Secures Pharmaceutical Registration Certificate from Macau Health Regulator

Stock News
·
Aug 17

Nancheng County Market Watch Intensifies Medical Supply Checks at Village Clinics

Deep News
·
Aug 17

HBM Holdings Schedules Board Meeting to Review Interim Results

Reuters
·
Aug 17

Dual-Listed Stock Premium Rankings: August 17 Closing Data

Stock News
·
Aug 17

Fictitious Profits Equated to 157% of Total Reported Income: A 2023 Loss Was Masked as Gains for This Company, Affected Investors May Be Eligible for Claims

Deep News
·
Aug 17

HEARTCARE-B Plans A-Share Issuance and STAR Market Listing

Deep News
·
Aug 17

BASECARE-B expects first-half revenue of 126-131 million yuan, up 24% to 29% year-on-year

Stock News
·
Aug 16

Suzhou Basecare Medical Expects H1 Revenue to Rise 24%-29% Y/Y

THOMSON REUTERS
·
Aug 16

Suzhou Basecare Expects H1 Loss Attributable to Shareholders to Narrow 39.5%-43.2% to RMB 69 Million-RMB 73.5 Million

Reuters
·
Aug 16

CanSino Biologics Says China's Nmpa Accepts New Drug Application for TD5cp Adolescent and Adult

THOMSON REUTERS
·
Aug 16

CanSino Biologics: Td5cp Vaccine for Adolescents and Adults Accepted for New Drug Review

Stock News
·
Aug 16

Profit Warning Triggers Sharp Decline in ACOTEC-B Stock as Key U.S. Clinical Trial Faces Hurdles

Stock News
·
Aug 16

Innovative Drug Sector's Rally from Lows Faces Divergence as Sustainability Hinges on Commercialization Proof

Deep News
·
Aug 16

Fund investors surprised as institutions sell into strength, with popular healthcare and medical ETFs seeing roughly 3 billion yuan in net outflows recently

Deep News
·
Aug 15